|
Hello fellow investors / traders,
What happens when a company records 14 consecutive growth quarters and receives a bullish rating from a prominent investing website? We sit up and take notice.
OXYS is a must see trade that we think has established a bottomed and could be see strong price appreciation in the short-medium term.
Why are we so confident that OXYS can deliver?
The company killed its recent earnings, with revenue up 52% over the past nine months (year over year), a cash balance of over $2 million and total assets over $4 million.
And the best news is the company is forecasting even more growth in 2016. They have forecast revenue of $10 million in 2016, up from its 2015 target of $5 million.
You can read all about their latest financials in more detail at http://finance.yahoo.com/news/oxysure-oxys-reports-third-quarter-123000689.html, but for now lets look at the technical reasons why OXYS could be a great trade.
OXYS is a highly liquid ticker that has been in a downtrend for most of 2015. It traded as high as $1.22, and now its at $0.27, just above its 52 week lows.
On Friday OXYS closed above its 50 day moving average for the first time in six months - a very bullish signal that a trend reversal could be in place.
Coupled with an uptick in the MACD, we think the technical signs are extremely bullish for OXYS, and Barchart.com agrees.
Put it this way, with 350% upside to reach its 52 week high, and just $0.10 downside to its 52 week low, the risk versus reward is definitely in the bulls favor now.
As seen in its financials, OXYS has been gaining much traction with its core business in recent times. In fact, they were the official supplier of medical equipment for the Special Olympic World Games held recently in Los Angeles.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions.
The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial,
mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.
In addition to oxygen products for public/lay responder usage, OxySure also markets emergency medical solutions including AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and HeartSine), Quickclot Bleeding Control solutions, resuscitation products and pulse oximetry products.
To learn more about OXYS, visit their website at http://www.oxysure.com/
I urge you to also read a summary of the company's financial performance as well as their business update and outlook (straight from the horse's mouth) at http://finance.yahoo.com/news/oxysure-oxys-reports-third-quarter-123000689.html
With the impressive revenue and asset growth OXYS has seen recently, its oversold share price and its small market cap of just $8m, we think this could be one heck of a ground floor opportunity.
ShiznitStocks.com
Disclaimer
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here.
ShiznitStocks.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein.
Instead ShiznitStocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. ShiznitStocks.com does not offer such advice or analysis, and ShiznitStocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's
investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a
number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or
"might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, ShiznitStocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing
additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, ShiznitStocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such
advertisement. ShiznitStocks.com is not responsible for any claims made by the companies advertised herein. ShiznitStocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in ShiznitStocks.com statements and opinions and such statements and opinions cannot be considered independent. ShiznitStocks.com reserves the right
to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, ShiznitStocks.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. ShiznitStocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the
companies profile. An affiliate of ShiznitStocks.com has been compensated two thousand dollars from a non-affiliated third party for the profile of OXYS. ShiznitStocks.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated ShiznitStocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the
same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If ShiznitStocks.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly
reflecting the current position of those free trading shares received as compensation for our services.
|